APBiotech Licenses GFP Technology from Aurora Biosciences | GenomeWeb

NEW YORK, Sept. 10 – Amersham Pharmacia Biotech has licensed green fluorescent protein technology from Aurora Biosciences, the company announced Monday.

The license gives APBiotech worldwide exclusive rights to the technology, said Kevin McCormack, marketing director for lead screening systems at APBiotech.

The company would not disclose the length of the licensing agreement or financial details of the agreement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.